The COA was exactly what we needed for our institutional approval process
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Xu L., Wu T., Lu S., Hao X., Qin J., Wang J., Zhang X., Liu Q., Kong B., Gong Y., et al
This article covers the chemical instability mechanisms that make glutathione storage so critical, the exact conditions required for each formulation type, and what happens when storage guidelines are ignored
Pipeline strategies include (i) AAV gene replacement for SLC52A2/A3 , (ii) brain-targeted delivery of active flavins, and (iii) small-molecule chaperones that stabilize misfolded transportersall of which will require biomarker-guided protocols and functional imaging endpoints to quantify long-term efficacy ( 3.2 Multiple acyl-CoA dehydrogenase deficiency Multiple acyl-CoA dehydrogenase deficiency (MADD) also known as glutaric academia type II or lipid-storage myopathyis caused by loss-of-function variants in ETFDH, ETFA, ETFB or, more rarely, FLAD1
